Showing 1151-1160 of 1583 results for "".
- Galderma's Restylane Silk Approved for Injection via Cannula for Lip Augmentationhttps://modernaesthetics.com/news/galdmeras-restylane-silk-approved-for-injection-via-cannula-for-lip-augmentation/2472175/The FDA approved the use of a small blunt tip cannula with Restylane Silk for lip augmentation. Galderma's Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specifically designed for lip augmentation and the smoothing of wrinkles around the mouth in patients 21 year
- Sciton Gives Back for Breast Cancer Awareness Monthhttps://modernaesthetics.com/news/sciton-gives-back-for-breast-cancer-awareness-month/2472194/Sciton, Inc.’s Women's Health Group division and the Young Survival Coalition (YSC) are partnering to raise awareness about women's vaginal health, in particular, those who are recovering from breast can
- Dr. Kelly Huang to Obalon; Alisa Lask to Oversee Galderma's Aesthetic & Corrective Business Unithttps://modernaesthetics.com/news/dr-kelly-huang-to-obalon-alisa-lask-to-oversee-galdermas-aesthetic-corrective-business-unit/2472202/Former Galderma general manager Kelly Huang, Ph.D. is now Obalon’s Chief Operating Officer. In this new role, Dr. Huang will be responsible for the key commercial functions of sales, marketing, operations, and quality assurance. In related
- Bonti's Gateway Neuromodulator Performs Well in Phase 2A Studyhttps://modernaesthetics.com/news/bontis-gateway-neuromodulator-performs-well-in-pase-2a-for-glabellar-lines/2472208/Bonti’s lead product candidate, EB- 001, passed muster in a Phase 2A study for the treatment of glabellar lines. EB-001 is a novel serot
- ThermiGen, an Almirall company, Names Vladimir Paul-Blanc President & General Managerhttps://modernaesthetics.com/news/thermigen-an-almirall-company-names-vladimir-paul-blanc-president-general-manager/2472245/Vladimir Paul-Blanc has been named President & General Manager of ThermiGen, LLC, starting May 1. He will report directly to the Executive Vice-president of Commercial Strategy of Almirall, Alfonso Ugarte, and he will be responsible for all general management responsibilities for the Thermi b
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- Galderma, Colorescience to Collaborate on Innovative Skincarehttps://modernaesthetics.com/news/galderma-colorescience-to-collaborate-on-innovative-skincare/2472266/Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable aesthetic treatments, the companies have announced. Galderma and
- Revealed: What A Girl Wants in a Plastic Surgeonhttps://modernaesthetics.com/news/revealed-what-a-girl-wants-in-a-plastic-surgeon/2472307/Nearly half of all female plastic surgery patients have no preference when it comes to the gender of their cosmetic surgeon, a new study show. Specifically, the report, published in Aesthetic Surgery Journal</
- Female Authorship Rises in Facial Plastic Surgery Literature, But Gaps Remainhttps://modernaesthetics.com/news/female-authorship-rises-in-facial-plastic-surgery-literature-but-gaps-remain/2486534/A cross-sectional bibliometric analysis published in Facial Plastic Surgery & Aesthetic Medicine examined trends in female authorship across facial plastic surgery literature from 2007 to 2022. The study evaluated 6,921 original research articles from 3 journals, assessing authorship
- Female Authorship Rises in Facial Plastic Surgery Literature, But Gaps Remainhttps://modernaesthetics.com/news/female-authorship-rises-in-facial-plastic-surgery-literature-but-gaps-remain/2486533/A cross-sectional bibliometric analysis published in Facial Plastic Surgery & Aesthetic Medicine examined trends in female authorship across facial plastic surgery literature from 2007 to 2022. The study evaluated 6,921 original research articles from 3 journals, assessing authorship